Skip to main content
. 2012 Oct 8;7(10):e46898. doi: 10.1371/journal.pone.0046898

Table 3. Clinical findings of patients with HAdv infection compared with other respiratory virus infections*.

Characteristic HAdv Other respiratory virus* p value
Cough, n/N (%) 463/547 (84.6) 8991/9643 (93.2) <0.001
Rhinorrhea, n/N (%) 429/531 (80.8) 8024/9499 (84.5) 0.023
Malaise, n/N (%) 435/545 (79.8) 8351/9638 (86.6) <0.001
Sore throat, n/N (%) 351/542 (64.8) 7372/9513 (77.5) <0.001
Headache, n/N (%) 286/542 (52.8) 6950/9605 (72.4) <0.001
Conjunctival injection, n/N (%) 269/529 (50.9) 4421/9363 (47.2) 0.104
Muscle soreness, n/N (%) 163/537 (30.4) 4666/9521 (49.0) <0.001
Eye pain, n/N (%) 100/524 (19.1) 3200/9393 (34.1) <0.001
Rhonchi, n/N (%) 67/527 (12.7) 1013/9340 (10.8) 0.182
Photophobia, n/N (%) 32/522 (6.1) 1017/9329 (10.9) 0.001
Dizziness, n/N (%) 25/524 (4.8) 1415/9333 (15.2) <0.001
Earache, n/N (%) 24/525 (4.6) 917/9340 (9.8) <0.001
Wheezing, n/N (%) 22/523 (4.2) 630/9331 (6.8) 0.023

Peru, 2000–2010.

*

Seasonal influenza A, Influenza A (H1N1) pdm09, HSV, influenza B, parainfluenza, enterovirus, HBoV, hMPV and respiratory syncytial virus. Those with co-infections or with missing responses were removed from the analysis.